Amelia is a dedicated marketing professional with a strong expertise in the field of in vitro diagnostics (IVD). Since joining PUSHKANG, a high-tech enterprise founded in 2014, she has played a crucial role in promoting the company's innovative solutions and expanding their market reach. With a deep understanding of the core technology platform centered around centrifugal microfluidics, Amelia effectively communicates the advantages of PUSHKANG's point-of-care testing (POCT) products, which cover areas such as coagulation, biochemistry, CLIA, and molecular testing.
Her passion for the IVD industry is reflected in the regular updates she provides through the company's professional blog. Through her well-researched articles, Amelia not only shares insights about PUSHKANG's cutting-edge products but also educates readers on the transformative impact these technologies can have on patient care. With a commitment to staying abreast of industry trends and advancements, Amelia ensures that PUSHKANG remains at the forefront of the IVD landscape, showcasing its strengths and driving forward the mission of enhancing diagnostic capabilities worldwide.
Her passion for the IVD industry is reflected in the regular updates she provides through the company's professional blog. Through her well-researched articles, Amelia not only shares insights about PUSHKANG's cutting-edge products but also educates readers on the transformative impact these technologies can have on patient care. With a commitment to staying abreast of industry trends and advancements, Amelia ensures that PUSHKANG remains at the forefront of the IVD landscape, showcasing its strengths and driving forward the mission of enhancing diagnostic capabilities worldwide.